XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Series D Preferred Stock [Member]
Series E Preferred Stock [Member]
Series E1 Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
Series D Warrants
Preferred Stock [Member]
Preferred Stock [Member]
Series D Preferred Stock [Member]
Preferred Stock [Member]
Series E Preferred Stock [Member]
Preferred Stock [Member]
Series E1 Preferred Stock [Member]
Additional Paid in Capital [Member]
Additional Paid in Capital [Member]
Series D Preferred Stock [Member]
Additional Paid in Capital [Member]
Series E Preferred Stock [Member]
Additional Paid in Capital [Member]
Series E1 Preferred Stock [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Series E Preferred Stock [Member]
Accumulated Deficit [Member]
Series E1 Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Balance at Dec. 31, 2018 $ (14,939)                   $ 329,065       $ (344,054)     $ 50
Balance (in shares) at Dec. 31, 2018         14,715   101                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Compensation expense for issuance of stock options 273                   273              
Compensation expense for issuance of restricted stock $ 4                   4              
Compensation expense for issuance of restricted stock (in shares) 20       20                          
Issuance of Preferred Stock   $ 150 $ 29,536 $ 9,510               $ 150 $ 42,876 $ 14,408   $ (13,340) $ (4,898)  
Issuance of Preferred Stock (in shares)               15 32,572 9,510                
Retirement of Series D Preferred Stock   $ (1,160)                   $ (1,160)            
Retirement of Series D Preferred Stock (in Shares)               (116)                    
Exercise of pre-funded warrants (in shares) 11,285         11,285                        
Exchange of warrants $ 13                   13              
Exchange of warrants (in shares)         92                          
Fair value of warrants issued (20,844)                   (20,844)              
Conversion of preferred stock into common stock 1                   1              
Conversion of Preferred stock into common stock (in shares)         13,455   (565)                      
Fractional rounding related to reverse stock split         $ 1           (1)              
Fractional rounding related to reverse stock split (in shares)         27,524                          
Net loss (8,879)                           (8,879)      
Comprehensive loss (22)                                 (22)
Balance at Dec. 31, 2019 (6,357)       $ 1           364,785       (371,171)     28
Balance (in shares) at Dec. 31, 2019         67,091   41,517                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Compensation expense for issuance of stock options $ 3,505                   3,505              
Compensation expense for issuance of restricted stock (in shares) 72,976                                  
Shares settled for services $ 406       $ 1           405              
Shares settled for services (in shares)         50,013                          
Shares settled for accrued compensation $ 230                   230              
Shares settled for accrued compensation (in shares)         22,963                          
Exercise of pre-funded warrants (in shares) 6,000                                  
Conversion of preferred stock into common stock $ (1)       $ 20           (21)              
Conversion of Preferred stock into common stock (in shares)         2,084,507   (20,887)                      
Registration costs of Series E and Series E-1 Preferred Stock and related warrants (106)                   (106)              
Fair value of warrants reclassified from liability to equity 6,200                   6,200              
Exercise of warrants into common stock 1,858       $ 2           1,856              
Exercise of warrants into common stock (in shares)         191,803                          
Public Offering - issuance of common stock and warrants 19,378       $ 18           19,360              
Public Offering - issuance of common stock and warrants (in shares)         1,823,000                          
ATM Offering 866       $ 1           865              
ATM Offering, Shares         77,644                          
Confidentially Marketed Public Offering - issuance of common stock 20,387       $ 17           20,370              
Confidentially Marketed Public Offering - issuance of common stock (in shares)         1,679,031                          
Fractional rounding related to reverse stock split (in shares)         49   1                      
Net loss (24,156)                           (24,156)      
Comprehensive loss (132)                                 (132)
Balance at Dec. 31, 2020 $ 22,078       $ 60           $ 417,449       $ (395,327)     $ (104)
Balance (in shares) at Dec. 31, 2020         5,996,101   20,631